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Background/aim: Pro-free radical oxidative stresses, as well as regulatory factors, are believed to be the key players in the development
of diabetes and heart-related disorders such as myocardial infarction. The aim of the present study was to highlight the role of oxidative
stress-responsive factors (reactive oxygen species [ROS], super oxide dismutase [SOD], and calpain-1) in type 2 diabetes and myocardial
infarction.
Materials and methods: A total of 100 type 2 diabetes patients with myocardial infarction and 50 normal individuals were selected for
this analysis. The levels of ROS and activities of SOD in the serum were determined. Serum calpain-1 expression was checked using
western blotting.
Results: The serum level of ROS and the expression of calpain-1 were significantly higher while the activity of SOD was significantly
lower in diabetic patients with myocardial infraction compared to normal individuals.
Conclusion: These findings suggest a possible link between decreased antioxidant (SOD) and increased ROS levels as well as calpain-1
expression, supporting the role of oxidative stress-regulatory factors in diabetes and myocardial infraction.
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1. Introduction
The term ‘myocardial infarction’ (MI) reflects the death of
cardiac myocytes. Myocardial cell death can be predicted
by the appearance of proteins that are generated by the
damaged myocytes (1). Mortality rates of diabetic patients
due to acute myocardial infarction are significantly higher
compared to nondiabetic patients, posing a serious threat
to diabetics (2–4). Persistent hyperglycemia leads to the
development of atherosclerosis. Within the endothelium,
hyperglycemia prevents nitric oxide production and its
bioavailability, leading to increased oxidative stress (5).
Reactive oxygen species (ROS), produced during
normal aerobic metabolism, are involved in signal
transduction and cognitive functions, but exceedingly
increased ROS concentrations also have harmful
effects (6). The potential sources of ROS production
in the cardiovascular system are numerous, consisting
of mitochondria, NADPH oxidase, xanthine oxidase,
activated neutrophils, NO synthases, and cyclooxygenases
(7), which lead to ischemia/reperfusion injury and an
increase in inflammatory cytokines (8). The free radicals are
neutralized by antioxidant action of both nonenzymatic as
well as enzymatic antioxidants (9). Superoxide dismutase
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(SOD) works as the first line of defense against ROS.
Recent studies have demonstrated that extracellular SOD
expression is decreased in the failing heart, and this is
associated with increased myocardial oxidative stress and
endothelial dysfunction (10).
Previous studies have documented the independent
role of ROS and calpain in myocardial cell deaths. Calpain-1
is a ubiquitous cytosolic Ca2+ activated neutral protease
(11,12). The physiological role of calpain-1 in organs like
the heart and its mechanism in diseased hearts are not
yet known, but studies indicate that calpain is activated
by Ca2+ overloads in diseased hearts, resulting in cardiac
dysfunction (13). Calpain-1 is involved in apoptosis by
cleaving Bax and promotes its proapoptotic activity (14–
17). Calmodulin and calpastatin are the 2 inhibitors of
calpain that reduce the expression and activity of calpain
(18,19). These inhibitors get proteolyzed during ischemia,
leaving calpain free to act on substrates. Calpain is also
involved in the apoptotic machinery by the activation of
caspase-12 and cytochrome c (20,21).
The present study delineates the expression of oxidative
stress regulators including ROS, SOD, and calpain
in diabetic MI. Regulation of their activities by ROS
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scavengers and calpain inhibitors may not only contribute
in preventing cellular damage but may also contribute in
regulating diabetes in its shift to MI at varying stages.
2. Materials and methods
2.1. Blood sample collection and serum extraction
All human sample collections were made according to
ethical regulations of the respective institutes. Blood
samples for biochemical analysis were collected in
Vacutainer tubes and immediately stored at 4 °C. Serum
was then separated as a supernatant by centrifugation at
4000 rpm for 5 min and stored at –20 °C until analysis.
2.2. ROS analysis of serum samples
The serum free radical level measurements were
carried out as follows (22). Briefly, N,N-diethyl-peraphenylenediamine (DEPPD) (R1) was dissolved in 0.1 M
sodium acetate buffer (pH 4.8) to get a final concentration
of 100 µg/mL and ferrous sulfate was dissolved in sodium
acetate buffer to attain a final concentration of 4.37 µM (R2).
R1 and R2 were mixed at a ratio of 1:25. This solution was
added as starter in a cuvette (3 mL) followed by a sodium
acetate buffer. Hydrogen peroxide (H2O2) was added as a
positive control and serum samples were analyzed for ROS
detection at 505 nm. Increase in absorbance was related to
elevated ROS concentrations.
2.3. SOD analysis of serum samples
SOD analysis of samples was carried out with
modifications as described previously (23). A reaction
mixture was prepared by taking phosphate-buffered saline
(NaCl, KH2PO4, Na2HPO4, and KCl), L-methionine,
nitro blue tetrazolium (NBT), and Triton X-100 followed
by the addition of the sample. After illumination with a
fluorescent lamp, riboflavin was added to initiate the
reaction. The sample mixture was delivered into cuvettes
and a measurement was taken at 560 nm. A control sample
without serum was also used in parallel.
2.4. Western blotting analysis
Expression of calpain-1 in patients and normal individuals
was assessed by western blotting. Serum samples were
subjected to sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and transferred onto a
nitrocellulose-supported transfer membrane with pore
size of 0.45 µm (Santa Cruz Biotechnology, USA) at
100 V for 2 h in a transfer buffer (25 mM Tris, 192 mM
glycine, and 20% methyl alcohol, pH 8.3) according to
the manufacturer’s instructions. After being blocked with
defatted milk, the membrane was incubated overnight
with a primary antibody (Santa Cruz Biotechnology)
using working dilutions of 1:1000 at 4 °C and then with
goat antirabbit IgG-AP at 1:10,000 dilutions (Santa
Cruz Biotechnology) for 1 h at room temperature. The
membrane was stained for 30 min in alkaline phosphatase

(AP) color development solution containing1 mL of 1X
AP reaction buffer with 50 µL of NBT solution and 50
µL of 5-bromo-4-chloro-3-indolyl phosphate solution
(Tiangen, China).
2.5. Statistical analysis
Statistical analysis was performed using SPSS 16. Multiple
linear regression tests were applied to calculate the
significant values. P < 0.05 was considered significant.
3. Results
3.1. Serum ROS level in diabetic MI patients
Patients suffering from type 2 diabetes and MI in
combination were considered as study subjects. In the
current study, 100 patients and 50 healthy individuals
were examined. The average level of ROS in the patients’
serum was 0.3062 ± 0.1539 and in the controls it was
0.1783 ± 0.0780. A significant increase in ROS levels was
foundin patients when compared to healthy controls
(Table), suggesting a linking role of free radicals in
diabetes mellitus and MI complications. ROS levels among
different parameters including sex, age, and hypertension
were nonsignificant. Serum ROS concentrations in
patients who smoked compared to normal subjects were
significantly increased when compared using multivariate
linear regression analysis (Table). These data suggest the
important role of smoking in diabetes as well as in diabetic
complications.
3.2. Antioxidant SOD activity
Serum SOD level, as an antioxidant, was measured. As
shown in the Table and Figures 1a–1c, SOD activity was
significantly decreased in diabetic patients with MI (45.53
± 11.88 ng/mL) compared to healthy subjects (76.36 ±
10.931 ng/mL). SOD activity significantly decreased in
diabetic patients, specifically in smokers.
3.3. Expression of calpain-1 in patients with type 2
diabetes and MI
The expression of calpain-1 in type 2 diabetes mellitus
patients with MI as well as in healthy individuals was
examined by immunoblotting (Figure 1). Comparatively,
more calpain expression was observed on immunoblots
from patients than from healthy individuals.
4. Discussion
MI commonly occurs when there is a rapid decline in
coronary blood flow following a thrombotic occlusion of
a coronary artery previously narrowed by atherosclerosis.
Diabetes mellitus is one of the features that increase
mortality in patients with acute MI (24). Many studies
focused on and assessed different oxidative stress-related
features in diabetes and MI individually, but there is a
lack of studies addressing both issues in combination. The
present study is based on analyzing the stress-responsive
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Table. Multiple linear regression analysis of determinants ROS and SOD in type 2 diabetic
patients with MI.
Variables

Patients (n = 100)

Standardized
coefficients (beta)

P-value

ROS (absorbance)
Patients/controls

0.3062/0.1783

0.430

<0.0001

Males/females

63%/37%

0.056

0.528

Age (<50/>50 years)

38%/62%

–0.042

0.634

Hypertension (HTN+/HTN–)

60%/40%

–0.009

0.924

Smokers/nonsmokers

72%/28%

0.550

<0.0001

SOD (ng/mL)
Patients/controls

46.53/91.5

–0.797

<0.0001

Males/females

63%/37%

0.103

0.167

Age (<50/>50 years)

38%/62%

–0.009

0.902

Hypertension (HTN+/HTN–)

60%/40%

0.017

0.827

Smokers/nonsmokers

72%/28%

–0.682

<0.0001

1: Patients

2: Control

120
ROS (absorbance at 505 nm)

0.5

SOD ng/mL

100
80
60
40
20
0

0.4
0.3
0.2
0.1
0

1

2

1

DM 2 and

MI

2

Normal

Calpain ‐1 (80 KDa)
Loading control

Figure 1. SOD, ROS, and calpain expression in diabetic and myocardial infarction patients. a) SOD activity in
diabetic and MI patients (1) and normal individuals (2): reaction mixture containing L-methionine, NBT, and Triton
was illuminated with a fluorescent lamp. After addition of riboflavin, SOD activity was analyzed in serum samples
at 560 nm. b) ROS concentrations in diabetic and MI patients (1) and normal individuals (2). The DEPPD method
was employed for detecting ROS at 505 nm, relating high absorbance rate with increased ROS concentrations. c) Blot
analysis of calpain-1 in serum of diabetic MI patients. The 6 left-side lanes represent calpain expression in diseased
samples and the extreme 2 right lanes represent normal healthy controls.

factors that in combination affect diabetes-linked MI and
may be helpful for designing future specified therapies for
diabetes-linked MI.
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Previously a relationship between MI and oxidative
stress, as well as altered concentrations of antioxidant
enzymes, was documented (10). In the current
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investigation, elevations of serum free radicals and
downregulation of SOD in patients with type 2 diabetes
and MI were observed when compared to normal subjects.
Furthermore, smoking is known to have a significant
positive association with the increase of production of
free radicals by polymorph nuclear leukocytes (25). In
the current study, increased ROS levels in patients with
smoking habits are consistent with previous findings and
suggest smoking as a contribution to diabetic complication
via ROS regulation. The present study shows a significant
increase of ROS to a certain extent, but the data of diabetic
MI patients as compared with normal controls show that
the increase in ROS is far greater. SOD activity was also
observed to be significantly reduced in MI and diabetic
patients, specifically in smokers, suggesting that increased
oxidative stress in smokers renders reduced activity of the
ROS scavenging machinery. Thus, we can conclude from
the present study that DM patients who smoke may be
more prone to MI than nonsmoking DM patients.
Previous studies indicated that calpain is of potential
importance in the regulation of the proteolysis of key
enzymes and structural proteins as well as proinflammatory
responses (26,27). However, as of yet, there is no
supporting study that indicates the role of calpain-1 in
diabetes; only its regulation of myocardial hypertrophy
has been revealed (28). Some studies suggested a possible
increase in expression of calpain-10 in pancreatic cells
during diabetes (29), but there is also a contradictory
study showing a decreased expression of calpain-10 during
diabetes (30). It is reported that in diabetes the calcium
level increases (31) and that may also serve as an activation
factor of calpain. Calpain and ROS both activate Bax and
increase mitochondrial permeabilization and caspase
release that ultimately play important roles in apoptosis
(32). Bax was previously reported to have a basic role in
the pathogenesis of myocardial infarction (33).

The results reported in this study show a high expression
of calpain-1. The increase in ROS is also proportional to
the increase in calpain. Calpain may be used as a possible
efficient diagnostic marker for DM-linked MI. We infer
that regulation of calpain-1 may, to some extent, play a role
in the management of the disease, or in its treatment, as it
also has a role in the apoptosis of cardiomyocytes (34). It is
also hypothesized that an increase in calpain may result in
apoptosis, which further leads to an increase in ROS due
to mitochondrial membrane dysfunction.
Limitations of the present study include the need
to understand in more detail the role of calpain-1. Its
molecular regulation should be elucidated fully in patients
with type 2 diabetes mellitus and MI. In the present
study we were also unable to place antioxidants into an
experimental model of diabetes and MI. Future studies
must be carried out to address these issues.
In conclusion, elevated ROS levels are observed in
type 2 diabetes mellitus patients with MI, whereas SOD
levels are reduced. As a result there is an imbalance
between oxidants and antioxidants that leads to the
generation of free radicals, suggesting a possible link
between these parameters and type 2 diabetes mellitus
with MI. Supplementation with antioxidants may alleviate
the production of ROS. Our study clearly showed stressresponsive factor calpain-1 expression in the serum of
patients. Further research should be carried out in this
new area of coronary heart diseases studies. The current
study presents new avenues for designing future specified
therapeutic interventions for type 2 diabetes patients with
MI.
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